This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In May 2024 , nearly 90% of pharmacies were closed for a day as thousands of pharmacists protested over “over drug shortages, pharmacy closures and fears medications could be sold online, as well as higher pay.”
According to data published this week by advisory Rock Health, startups using AI made up 37% of 2024’s digital health funding. Since OpenAI’s ChatGPT launched a wave of enthusiasm about the potential of AI, the technology has become a specific target for health care investors.
It had been five months since I’d applied to the program, after being discharged from the hospital in August 2024 as a new full-time wheelchair user. The letter informed me that I had been approved for Medicaid-funded Home and Community-Based Services (HCBS), a form of long-term care.
billion in 2024, according to GlobalData. Additionally, Arrowhead Pharmaceuticals made headlines in 2024 with a $2.18 billion in 2024, reveals GlobalData appeared first on Express Pharma. However, Ionis Pharmaceuticals, leads the field with $13.4 The post CNS innovator oligonucleotide licensing value surges by 339% to $2.8
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations.
The company indicated that the investigation began in 2017 and picked up in intensity in late 2024 and early 2025. The SEC filing states that on Feb. Continue to STAT+ to read the full story…
Working with law enforcement partners between December 2024 and May 2025, the MHRA’s Criminal Enforcement Unit (CEU) seized […] The post Estimated £17.2m worth of illegal medicines seized by MHRA appeared first on The Pharmacist.
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. I’ll be joined by special guest Antonio Ciaccia, CEO of 46brooklyn Research, and President of 3 Axis Advisors. Click here to see the original post from April 2025.
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Megablockbusters are the holy grail.
For 2024, nearly 80% of all equivalent prescription claims were processed by three familiar companies: the CVS Caremark business of CVS Health, the Express Scripts business of Cigna, and the Optum Rx business of UnitedHealth Group. I’ll be joined by special guest Antonio Ciaccia, CEO of 46brooklyn Research, and President of 3 Axis Advisors.
Drug Channels Institute (DCI) estimates that the gross-to-net reductions for all brand-name drugs reached $356 billion in 2024, a 7% increase over the previous year. Is the gross-to-net bubble —the ever-widening gap between brand-name drug sales at list prices and their net revenues after rebates and discounts—finally beginning to deflate?
For 2024, DCI estimates that total prescription dispensing revenues at retail, mail, long-term care, and specialty pharmacies reached $683 billion, up 9% from the 2023 figure. It’s the 16th edition of our popular and comprehensive examination of the entire U.S. drug pricing, reimbursement, and dispensing system.
Innovator oligonucleotide-based drugs targeting central nervous system (CNS) indications witnessed a 339% ($2.17bn) increase in total licensing agreement deal value from 2023 to 2024, reaching a total deal value of $2.81bn, according to GlobalData’s Pharma Intelligence Center Deals Database.
Sterility assurance and gowning violations (Form 483 – March 2024) Operators were observed performing interventions with improperly disinfected gloves and exposed gown interfaces. Any contamination should trigger a deep, multidisciplinary investigation, supported by environmental and personnel data, with appropriate CAPA and revalidation.
hospitals are increasingly integrating pharmacists into clinical care, but many are struggling to fill roles and maintain staff, according to the 2024 American Society of Health-System Pharmacists National Survey of Pharmacy Practice in Hospital Settings.
Both drugs were among the top-selling drugs in 2024, with Keytruda leading by generating over $29 billion. These drugs accounted for a significant share of the company’s 2024 revenue, and their patent expirations could significantly weaken its overall financial performance.
In a letter sent to the company, the lawmaker maintained that the decision to discontinue its inhaler in January 2024 has since had “life-threatening consequences for patients” and contributed to a spike in hospitalizations. Maggie Hassan (D-N.H.)
Streamlined Approval of Biosimilars: Moving On From The Confirmatory Efficacy Trial. 2020;25(11):1910-1918. Biosimilar Medicines: Overview. European Medicines Agency. Available from: [link] European Commission. Pharmaceutical Strategy for Europe. COM(2020) 761 final. Streamlining Development And Assessment Of Biosimilar Medicines.
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from First 90 Days A biopharma doubles down on (..)
A Further Examination of Pharmacy Benefit Managers Nicholas Saraceno, Editor March 29th 2024 Podcast Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.
Indeed, in 2024, the Nobel Prize in Chemistry was awarded to the DeepMind team for their work on AlphaFold [ii] , an AI system that accurately predicts protein structures. link] [iv] [link] [v] [link] [vi] GlobalData: Artificial Intelligence in Healthcare, September 2024 [vii] QuantumPharm Inc 2024, prospectus. Front Genet.
14,15 Lung Cancer Tarlatamab Significantly Improves Survival in Patients With Small Cell Lung Cancer Post Progression Tarlatamab has shown promising efficacy in relapsed SCLC based on the initial single-arm trial findings, leading to an FDA approval in 2024, but challenges with administration have limited its widespread adoption.
Since implementing the technology in April 2024, 86% of users report less burnout, 83% report improved work-life balance and job satisfaction, 80% report better patient experience, and 3 in 4 say they are less likely to leave clinical practice. based AdventHealth are using Nuance’s DAX Copilot ambient AI scribe.
Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in Harbour BioMed partners Otsuka on new T-cell therapy Madrigal poised to enter European MASH market after CHMP endorsement Themes Sections Artificial Intelligence Cloud Corporate Governance (..)
By 2024, more than 750 Indian facilities were registered with the U.S. In FY 2024–25, India’s pharmaceutical exports exceeded USD 30.3 Furthermore, FDA Warning Letters issued between 2020 and 2024 show a disproportionately higher number of citations for sterile product manufacturers. Source: Pharmexcil, 2024 Annual Report 2.
5 Phase 3 ECHO Trial: A New Frontline Option The approval was supported by data from the phase 3 ECHO trial (NCT02972840), presented at the 2024 European Hematology Association Hybrid Congress. June 21, 2024. Deaths were reported in 5 TN and 6 R/R patients. The trial enrolled 598 patients 65 years or older with TN MCL. Hemasphere.
9, 2024—seven weeks before the one-year stabilization period was set to end. Stakeholders are aware that this federal law—enforced by the FDA and originally enacted in 2013 as a way to help bolster security and traceability of products passing through the pharma supply chain—has seen its share of delays and exemptions over the years.
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from First 90 Days As its cancer vaccine moves (..)
The FDA approved nemolizumab in December 2024 for the treatment of moderate-to-severe atopic dermatitis in combination with topical corticosteroids and/or calcineurin inhibitors when the disease is not controlled by topical prescription therapies among individuals 12 and older. May 15, 2024. December 16, 2024. June 6, 2025.
Updated April 2, 2024. A study of JNJ-68284528, a chimeric antigen receptor T cell (CAR-T) therapy directed against B-cell maturation antigen (BCMA) in participants with relapsed or refractory multiple myeloma (CARTITUDE-1). Accessed June 24, 2025.
Since launching the service in September 2024, they’ve dispensed more than 300 boxes, with an estimated 72% acceptance rate. When patients are prescribed an opioid for the first time, the system alerts staff for a clinical consult. 1 This service can not only expand pharmacies’ clinical offerings but serves a crucial public health benefit.
This phase 1b clinical trial, conducted between September 2023 and November 2024, was designed to build on promising preclinical data that demonstrated improved efficacy and tolerability with continuous SC lenalidomide delivery in murine MM models.
The company ranks as the second fastest-growing firm among the top 30 in terms of domestic sales between MAT December 2021 and MAT December 2024. As of 31 December 2024, CORONA Remedies had a workforce of 4,470 and two facilities covering an aggregate of 2.83 These facilities have a total installed formulation capacity of 1,285.44
Updated September 10, 2024. TOC services are one of many areas where pharmacy models can improve patient outcomes, quality metrics, and hospital revenue. 4-6 Since this study’s completion, the institution has expanded its protocol with additional prescribing opportunities for TOC pharmacists and plans to expand services to non-HRRP patients.
By 2024, Fortune Business Insights estimated the market had already doubled to USD 127.95 A Global Surge: Online Pharmacies on the Rise The global ePharmacy market was valued at approximately USD 60.0 billion in 2022, and forecasts indicate it will expand at a compound annual growth rate (CAGR) of 20.4% billion by 2032.
September 11, 2024. Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study. News release. Accessed June 18, 2025.
1 The current post hoc secondary analysis was conducted from March to June 2024 and aimed to further evaluate the spillover of an audit-and-feedback intervention that targets individuals aged 65 and older on a broader population of all age groups.
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Q&A Need a DTC platform?
The document marks the first publication by the Obesity Management Collaborative UK, a professional network established in 2024 to support clinicians managing obesity. I’ve seen patients in primary care who are clearly taking the medications, but they haven’t been given wrap-around care.”
5 (May 10, 2024): e240921, [link] 6 Medicare Payment Advisory Commission, Report to the Congress: Medicare and the Health Care Delivery System , Chapter 2, “Medicare Part B Drug Payment Policy Issues” (Washington, DC: MedPAC, June 2017), [link] www.medpac.gov/wp-content/uploads/import_data/scrape_files/docs/default- source/reports/jun17_ch2.pdf.
billion in 2024, is expected to skyrocket to $69.2 This often pushes them towards telehealth , which can offer much faster care (3-6 weeks). The telehealth boom , fueled by the pandemic, has transformed how people access care. The virtual care market, valued at $7.1 billion by 2034.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content